February 2014 Global Forum Now Online: Some experts predict that the global market for biosimilars – biological products that are demonstrated to be "biosimilar to" or "interchangeable with" a licensed biological product – may double between today and 2017. This new Special Section presents complementary regulatory and industry perspectives on the emerging science and technology of biosimilars. Also Featured: Our joint Q&A with both DIA 2014 50th Annual Meeting Co-chairs, our Profile interview with Dr. Murray M. Lumpkin of The Bill & Melinda Gates Foundation, and DIA’s extensive analysis of “What Lies Ahead?” for 2014.
Read current issue.
Browse all issues.
The Global Forum includes:
- Important news from DIA conferences and workshops
- DIA Board of Director and Regional Advisory Council reports—news that directly impacts DIA members
- Practical tips, regulatory and global updates, upcoming DIA events, program notes, and much more
Download author guidelines (PDF).
Opt-in to receive DIA emails.
||DIA 2013 49th Annual Meeting Professional Poster Abstracts
Over 60 Professionals from all fields related to the mission of DIA presented their original research in the form of a poster at this year’s DIA 49th Annual Meeting “Advancing Therapeutic Innovation and Regulatory Science” in Boston, Massachusetts. Now you can read the abstracts of posters presented at this year’s program in this first ever addendum from this year’s Annual Meeting Program, beginning on page 106 of your August Global Forum (open the current issue, then click the “Back Issues” tab to locate and open the August issue).
Questions regarding this year’s Professional Poster program?